ACELARATE: A phase III, open label, multicentre randomised clinical study comparing Acelarin (NUC-1031) with gemcitabine in patients with metastatic pancreatic carcinoma.



Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ross, Paul J, Silcocks, Paul, Greenhalf, William, Faluyi, Olusola Olusesan, Ma, Yuk Ting, Wadsley, Jonathan, Rawcliffe, Charlotte Louise, Valle, Juan W and Neoptolemos, John P
(2018) ACELARATE: A phase III, open label, multicentre randomised clinical study comparing Acelarin (NUC-1031) with gemcitabine in patients with metastatic pancreatic carcinoma. .

Access the full-text of this item by clicking on the Open Access link.
Item Type: Conference or Workshop Item
Depositing User: Symplectic Admin
Date Deposited: 27 Nov 2018 10:33
Last Modified: 28 Nov 2019 08:16
DOI: 10.1200/JCO.2018.36.4_suppl.TPS537
Open Access URL: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.4_...
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3028969
Repository Staff Access